Tempest Therapeutics, Inc. — Revenue by Fiscal Year
5 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/6f74df77-6afe-4f5b-b7af-bd8060e9c642/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2017 | $295.0k | 2017-01-01 – 2017-12-31 | evidence 0001544227-18-000002 |
| FY 2016 | $653.0k | 2016-01-01 – 2016-12-31 | evidence 0001544227-17-000002 |
| FY 2015 | $277.0k | 2015-01-01 – 2015-12-31 | evidence 0001544227-16-000008 |
| FY 2014 | $0 | 2014-01-01 – 2014-12-31 | evidence 0001544227-16-000008 |
| FY 2013 | $0 | 2013-01-01 – 2013-12-31 | evidence 0001544227-16-000008 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Tempest Therapeutics, Inc. — all facts · Net Income · Operating Income